NCAPH
Basic information
Region (hg38): 2:96335766-96377091
Previous symbols: [ "BRRN1" ]
Links
Phenotypes
GenCC
Source:
- microcephaly 23, primary, autosomal recessive (Limited), mode of inheritance: Unknown
- microcephaly 23, primary, autosomal recessive (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Microcephaly 23, primary, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 27737959 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (98 variants)
- not_provided (11 variants)
- NCAPH-related_disorder (8 variants)
- Microcephaly_23,_primary,_autosomal_recessive (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NCAPH gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015341.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | |||||
| missense | 99 | 108 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 1 | 1 | 99 | 11 | 2 |
Highest pathogenic variant AF is 0.0000034581637
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| NCAPH | protein_coding | protein_coding | ENST00000240423 | 18 | 38059 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000801 | 1.00 | 125714 | 0 | 33 | 125747 | 0.000131 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.09 | 353 | 416 | 0.849 | 0.0000223 | 4918 |
| Missense in Polyphen | 89 | 134.43 | 0.66208 | 1692 | ||
| Synonymous | 1.05 | 143 | 160 | 0.894 | 0.00000944 | 1383 |
| Loss of Function | 3.61 | 14 | 38.1 | 0.368 | 0.00000196 | 456 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000871 | 0.0000871 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000568 | 0.0000544 |
| Finnish | 0.000325 | 0.000323 |
| European (Non-Finnish) | 0.000133 | 0.000123 |
| Middle Eastern | 0.0000568 | 0.0000544 |
| South Asian | 0.000165 | 0.000163 |
| Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. {ECO:0000269|PubMed:11136719}.;
- Pathway
- Condensation of Prometaphase Chromosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Aurora B signaling
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.655
- rvis_EVS
- -0.31
- rvis_percentile_EVS
- 32.17
Haploinsufficiency Scores
- pHI
- 0.640
- hipred
- Y
- hipred_score
- 0.765
- ghis
- 0.657
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.264
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ncaph
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Zebrafish Information Network
- Gene name
- ncaph
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- mitotic chromosome condensation;meiotic chromosome condensation;cell division;female meiosis chromosome separation;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity
- Cellular component
- condensin complex;nuclear condensin complex;nucleus;cytosol;membrane
- Molecular function
- chromatin binding;protein binding;DNA topoisomerase binding;DNA topoisomerase (ATP-hydrolyzing) activator activity